Kyverna Therapeutics (KYTX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

KYTX Kyverna Therapeutics

Watchlist

4.390
+0.400+10.03%

Close Nov 22 16:00 ET

4.380
-0.010-0.23%

Post 20:01 ET

189.52MMarket Cap-1712P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Kyverna Therapeutics Analyst Ratings
BenzingaNov 20 07:58 ET · Ratings
H.C. Wainwright Maintains Kyverna Therapeutics(KYTX.US) With Hold Rating, Cuts Target Price to $6
Moomoo NewsNov 20 06:31 ET · Ratings
Institutional Investors of Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Must Be Disappointed After Last Week's 18% Drop
Yahoo FinanceNov 17 08:14 ET
Kyverna Therapeutics Is Maintained at Overweight by Wells Fargo
Dow JonesNov 15 14:22 ET · Ratings
Wells Fargo Maintains Kyverna Therapeutics(KYTX.US) With Buy Rating, Cuts Target Price to $24
Moomoo NewsNov 15 08:35 ET · Ratings
Express News | Kyverna Therapeutics, Inc. : Wells Fargo Cuts Target Price to $24 From $44
ReutersNov 15 06:13 ET

Comments

Jaguar8

Nov 14 09:36

NEWS

$Kyverna Therapeutics (KYTX.US)$
Kyverna Therapeutics Announces New Patient Data Highlighting Potential of KYV-101 for Treatment of Lupus Nephritis in Symposium at ACR Convergence 2024
Kyverna Therapeutics presented updated clinical data for KYV-101, their CD19 CAR T-cell therapy for lupus nephritis (LN) treatment. The data shows sustained efficacy and durability in patients treated with the target dose of 1×108 CD19 CAR T cells, with four out of six patients having at least six months of fol...

Stock_Drift

Nov 14 09:07

$Kyverna Therapeutics (KYTX.US)$

Stock_Drift

Oct 14 15:21

After Hours Ticks. 4:18pm 10/14

$CNFinance (CNF.US)$ $Alternus Clean Energy (ALCE.US)$ $Molecular Templates (MTEM.US)$ $Edible Garden (EDBL.US)$ $Sonder Holdings (SOND.US)$ $PHX Minerals (PHX.US)$ $Kyverna Therapeutics (KYTX.US)$ $Spectral AI (MDAI.US)$ $Gritstone Bio (GRTS.US)$ $Healthpeak Properties (DOC.US)$ $Bright Minds Biosciences (DRUG.US)$

SometimezInTheGreen

Jul 16 13:55

I like the uptrend today!

$Kyverna Therapeutics (KYTX.US)$

Jaguar8

Jul 15 15:06

NEWS

$Kyverna Therapeutics (KYTX.US)$
Kyverna's KYV-101 Receives U.S. FDA RMAT Designation for KYV-101 in the Treatment of Patients With Refractory Stiff-Person Syndrome
Kyverna Therapeutics (KYTX) has received Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA for KYV-101, its autologous CD19 CAR T-cell therapy, in treating refractory stiff-person syndrome. This designation, based on positive clinical outcomes in Germany, allows Kyverna to receive expert guidance on efficient ...